Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Corem Property Group Pref | COREPREF | Sep 30, 2024 | 288.50 | -0.86 |
Corline Biomedical | CLBIO | Sep 30, 2024 | 8.44 | +6.57 |
Cortus Energy | CE | Sep 30, 2024 | 0.26 | -7.91 |
Creades A | CREDA | Sep 30, 2024 | 83.15 | +2.09 |
Creturner Group | CRET | Sep 30, 2024 | 0.15 | -11.56 |
Crown Energy | CRWN | Sep 30, 2024 | 0.68 | 0.00 |
Crunchfish | CFISH | Sep 30, 2024 | 1.97 | +0.51 |
CTEK | CTEK | Sep 30, 2024 | 18.94 | +0.74 |
CTT Systems | CTT | Sep 30, 2024 | 272.00 | -1.09 |
Curasight | CURAS | Sep 30, 2024 | 10.00 | -0.99 |
Cyber Security 1 | CYB1 | Sep 30, 2024 | 0.01 | 0.00 |
Cyclezyme AB | CYCLE | Sep 30, 2024 | 10.10 | -2.88 |
Cyxone | CYXO | Sep 30, 2024 | 0.04 | -2.50 |
Dala Energi | DE | Sep 30, 2024 | 87.20 | -1.13 |
Dedicare B | DEDI | Sep 30, 2024 | 67.50 | -0.44 |
Desenio | DSNO | Sep 30, 2024 | 0.43 | +2.38 |
Deversify Health | DEV | Sep 30, 2024 | 0.01 | 0.00 |
DevPort | DEVPB | Sep 30, 2024 | 32.30 | -0.31 |
Devyser Diagnostics | DVYSR | Sep 30, 2024 | 127.00 | -0.39 |
DexTech Medical | DEX | Sep 30, 2024 | 4.60 | +0.44 |
Diadrom Holding | DIAH | Sep 30, 2024 | 9.10 | -1.09 |
Diagonal Bio | DIABIO | Sep 30, 2024 | 0.01 | -9.57 |
Diamyd Medical B | DMYDB | Sep 30, 2024 | 15.26 | +5.68 |
Dicot Pharma AB | DICOT | Sep 30, 2024 | 0.17 | +0.24 |
Dignitana | DIGN | Sep 30, 2024 | 0.88 | -0.57 |
DistIT | DIST | Sep 30, 2024 | 5.18 | +4.02 |
Dividend Sweden AB | DIVB | Sep 30, 2024 | 0.32 | +3.23 |
Divio Technologies B | DIVIOB | Sep 30, 2024 | 0.22 | -5.98 |
Diös Fastigheter | DIOS | Sep 30, 2024 | 87.55 | -0.28 |
Dlaboratory Sweden | DLAB | Sep 30, 2024 | 2.22 | -2.20 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.